000 01182 a2200313 4500
005 20250517151419.0
264 0 _c20180423
008 201804s 0 0 eng d
022 _a1573-7365
024 7 _a10.1007/s11011-017-0015-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCzuba, Ewelina
245 0 0 _aCholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions.
_h[electronic resource]
260 _bMetabolic brain disease
_c08 2017
300 _a935-948 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBlood-Brain Barrier
_xmetabolism
650 0 4 _aBrain Diseases
_xmetabolism
650 0 4 _aCholesterol
_xmetabolism
650 0 4 _aHumans
650 0 4 _aNerve Degeneration
_xmetabolism
650 0 4 _aNeurons
_xmetabolism
700 1 _aSteliga, Aleksandra
700 1 _aLietzau, Grażyna
700 1 _aKowiański, Przemysław
773 0 _tMetabolic brain disease
_gvol. 32
_gno. 4
_gp. 935-948
856 4 0 _uhttps://doi.org/10.1007/s11011-017-0015-3
_zAvailable from publisher's website
999 _c27103218
_d27103218